Bullish (BLSH) Stock Gains 4% Despite ARK Invest's Latest Selloff

Key Takeaways

Table of Contents

On March 23, ARK Invest divested 39,362 shares of Bullish (BLSH) valued at approximately $1.56 million through its ARKK and ARKW funds
The stock advanced 4.16% during the trading session, finishing near $39.55
Three days prior on March 20, ARK offloaded 103,379 BLSH shares totaling roughly $3.93 million
These sales follow ARK’s substantial February 2026 accumulation of about 2.1 million BLSH shares valued between $58–$60 million across nine trading days
Wall Street analysts maintain a Moderate Buy rating on BLSH with a consensus price target of $47.83, suggesting approximately 20.9% potential upside

On Monday, March 23, Cathie Wood’s ARK Invest divested a total of 39,362 shares in Bullish (BLSH), valued at approximately $1.56 million, during a trading session that saw the cryptocurrency exchange stock surge 4.16%.

Bullish, BLSH

The divestment was executed across two separate exchange-traded funds: the ARK Innovation ETF (ARKK) reduced its holdings by 31,154 shares, while the ARK Next Generation Internet ETF (ARKW) sold off 8,208 shares. BLSH concluded trading at $39.55 per share.

This represents part of a broader selloff pattern. On March 20, ARK had already reduced its BLSH position by 103,379 shares, representing approximately $3.93 million in value — a substantially larger transaction that received less attention than Monday’s activity.

Combined, the two selling events total 142,741 shares with an aggregate value near $5.5 million. This comes after months of substantial position building by ARK Invest.

During February 2026, ARK conducted an intensive nine-day acquisition campaign in BLSH, accumulating roughly 2.1 million shares at a cost between $58–$60 million. These purchases followed a stock decline triggered by earnings results.

Financial Performance Breakdown

Bullish’s fourth-quarter 2025 results showed adjusted revenue reaching $92.5 million with adjusted EBITDA of $44.5 million, marking year-over-year growth in both metrics. The company posted a net loss of $563.6 million, though adjusted net income showed improvement at $28.9 million.

The crypto exchange processed $64.3 billion in digital asset transactions during the quarter, representing a modest decline from previous periods. Management issued 2026 guidance projecting subscription, services, and other revenue between $220 million and $250 million.

For the full year, adjusted operating expenses are forecast to range from $210 million to $230 million.

Strategic Rationale Behind the Reduction

The recent share sales appear to represent tactical portfolio management rather than a fundamental shift in investment thesis. ARK Invest has demonstrated a consistent pattern of accumulating BLSH shares during price weakness and reducing positions during strength — Monday’s divestment aligns perfectly with this approach, occurring as the stock climbed over 4%.

ARK is simultaneously reallocating capital into biotechnology investments. The same day, the firm acquired 98,722 shares of 10X Genomics (TXG) worth $1.89 million, also during a 4.08% price advance for that stock.

Cryptocurrency-related equities like BLSH typically exhibit significant volatility correlated with Bitcoin price movements and regulatory developments, making them logical candidates for profit-taking following strong performance periods.

According to TipRanks data, BLSH maintains a Moderate Buy consensus rating supported by four Buy recommendations and two Hold ratings. The average Wall Street price target stands at $47.83, indicating potential upside of approximately 20.9% from current trading levels.

✨ Limited Time Offer